It is widely acknowledged that IDH mutated status and 1p/19q codeletion status are vital prognostic factors of diffuse gliomas; therefore, the appearance of these two mutated genes along with IDH mutation and 1p/19q codeletion might similarly infer a good prognosis of gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.